157.05 - 162.11
76.48 - 186.65
30.24M / 54.17M (Avg.)
94.92 | 1.68
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.32%
Revenue growth 0-5% – Minimal but still positive. Howard Marks would watch for potential stagnation or cyclical headwinds.
-10.56%
Negative gross profit growth suggests either falling sales or rising direct costs. Benjamin Graham would consider this a fundamental warning sign.
-103.31%
Negative EBIT growth points to weakening core profitability. Benjamin Graham would question management efficiency.
-116.63%
Negative operating income growth means rising costs or falling revenues are eroding core profitability. Benjamin Graham would raise caution.
22.99%
Net income growth 15-25% – Strong profitability improvement. Warren Buffett might see if these gains are sustainable across cycles.
22.73%
EPS growth 15-25% – Very strong. Benjamin Graham might verify if any one-time gains or tax benefits artificially inflate EPS.
22.73%
Diluted EPS growth 15-25% – Very strong. Benjamin Graham would verify that no large one-time items are skewing the diluted figure.
0.19%
Share count up to +3% – Slight dilution. Howard Marks would be cautious but might accept it if used for profitable growth investments.
0.25%
Diluted share count up to +3% – Modest dilution. Howard Marks might tolerate it if used for high-ROI projects or strategic acquisitions.
No Data
No Data available this quarter, please select a different quarter.
114.16%
OCF growth above 20% – Exceptional cash generation improvement. Warren Buffett might see if the net margin also rises in tandem.
137.83%
FCF growth above 20% – Very attractive to value investors. Warren Buffett would check if capital expenditures remain sensible to maintain this level.
291.07%
10Y revenue/share CAGR above 15% – Exceptional long-term expansion. Warren Buffett would confirm if growth is organic, not purely from acquisitions.
187.73%
5Y CAGR above 15% – Robust mid-term revenue/share growth. Warren Buffett might ensure net margins are rising alongside top-line expansions.
16.97%
3Y CAGR above 15% – Rapid short-term revenue/share growth. Warren Buffett would see if margins are stable, ensuring profitable expansion.
1762.05%
10Y OCF/share CAGR above 15% – Outstanding long-term cash-generation growth. Warren Buffett would check if reinvestment needs remain manageable.
498.63%
5Y OCF/share CAGR above 15% – Very robust mid-term cash expansion. Warren Buffett would check if reinvestment fosters sustainable growth.
93.14%
3Y OCF/share CAGR above 15% – Rapid short-term expansion. Warren Buffett would see if this stems from genuine operational improvements vs. working-capital swings.
330.94%
10Y net income/share CAGR above 15% – Exceptional long-term profit growth. Benjamin Graham would confirm if these gains hold through economic cycles.
301.76%
5Y net income/share CAGR above 15% – Strong mid-term profit growth. Benjamin Graham would check if leverage artificially boosts earnings.
94.48%
3Y net income/share CAGR above 15% – Rapid short-term profit growth. Benjamin Graham would verify if it’s driven by core revenue or temporary cost reductions.
20384.37%
10Y equity/share CAGR above 12% – Excellent long-term book value compounding. Warren Buffett would see if consistent profits plus moderate payouts drive this growth.
1205.86%
5Y equity/share CAGR above 12% – Strong mid-term book value expansion. Warren Buffett would see if steady profits and moderate payout ratios sustain this pace.
7.82%
3Y equity/share CAGR 5-8% – Solid. Seth Klarman might see a healthy short-term ROE fueling book value growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-18.63%
Negative receivables growth can be good if demand remains stable. Benjamin Graham verifies it isn’t from a collapse in sales.
4.07%
Inventory growth 0-5% – Generally fine if revenue grows similarly. Seth Klarman confirms no shortage risk that could hamper sales.
4.57%
Asset growth 0-5% – Minimal. Howard Marks notes the firm may be optimizing existing assets or being cautious with expansions.
2.89%
2-5% annual BV/share growth – Mild. Peter Lynch sees potential if expansions or margin lifts can accelerate compounding.
-17.86%
A negative growth rate in debt means deleveraging, often positive for conservative investors. Benjamin Graham confirms it doesn’t restrict needed investments.
9.61%
R&D growth 0-10% – Balanced approach. Seth Klarman sees manageable cost if new products are still in development.
11.85%
SG&A growth 10-15% – Potential overhead buildup. Howard Marks questions if margins shrink unless revenue scales accordingly.